Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-780
Closed -$89K 129
2024
Q3
$89K Sell
780
-765
-50% -$90.9K 0.04% 72
2024
Q2
$191K Hold
1,545
0.1% 60
2024
Q1
$204K Hold
1,545
0.12% 52
2023
Q4
$168K Hold
1,545
0.09% 48
2023
Q3
$159K Hold
1,545
0.09% 49
2023
Q2
$178K Hold
1,545
0.08% 57
2023
Q1
$164K Hold
1,545
0.08% 57
2022
Q4
$171K Buy
+1,545
New +$158K 0.08% 57
2020
Q4
Sell
-24,759
Closed -$1.96M 125
2020
Q3
$1.96M Hold
24,759
0.85% 18
2020
Q2
$1.83M Hold
24,759
1.23% 13
2020
Q1
$1.82M Buy
+24,759
New +$1.95M 1.7% 14

Other funds holding MRK

NKCFO LLC's MRK Position: Q4 2024 in Review

NKCFO LLC sold out of Merck (MRK) in Q4 2024, closing a stake of 780 shares — an estimated $89K sold.

NKCFO LLC first reported a position in MRK in Q1 2020 and held it in 11 quarters. The position peaked at $1.96M in Q3 2020. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • NKCFO LLC reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • NKCFO LLC sold 780 Merck shares in Q4 2024, an estimated $89K.
  • NKCFO LLC first reported a position in Merck in Q1 2020 and held it in 11 quarters.
  • NKCFO LLC's Merck position peaked at $1.96M in Q3 2020.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on NKCFO LLC's 13F filing for Q4 2024, filed 30 Jan 2025.